NSECertificate under SEBI (Depositories and Participants) Regulations, 20185 Oct 2026 · 5 Oct 2026, 05:45 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Symbiotec Pharmalab Limited · SYMBIOTEC
✦ AI Summary
Symbiotec Pharmalab Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Symbiotec Pharmalab Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026
Attachments (1)
📄pdf
Download →
SYMBIOTEC_05102026174444_ComplianceCertirficate__74_5_ofDPRegulation_.pdf
View document text
October 05, 2026
To, To,
BSE Limited, National Stock Exchange of India Ltd.,
Phiroze Jeejeebhoy Towers, Exchange Plaza,
Dalal Street, Bandra Kurla Complex,
Mumbai – 400001 Bandra (East), Mumbai – 400051
Scrip code: 544889 Symbol: SYMBIOTEC
Sub: Certificate pursuant to Regulation 74(5) of Securities and Exchange Board of India
(Depositories and Participants) Regulations, 2018
Dear Sir/ Madam,
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we
hereby enclose certificate received from MUFG Intime India Private Limited, the Registrar and
Share Transfer Agent of the Company, for the quarter ended September 30, 2026.
The aforesaid information is also being made available on the Company's website i.e.
https://investor.symbiotec.com/announcements
Kindly take the same on record.
Thanking you,
For Symbiotec Pharmalab Limited
Salil Jain
Company Secretary & Compliance Officer
Encl.: As above
Registered Office & Works:
Symbiotec Pharmalab Limited
(Formerly known as Symbiotec Pharmalab Pvt. Ltd.)
385/2, Pigdamber, Rau, Mhow, Indore - 453331, Madhya Pradesh, India
Tel. No.: +91-731-6676405-406 Fax: +91-731-4201222,
Email ID : symbiotec@symbiotec.com, Website : www.symbiotec.com
CIN: U24232MP2002PLC015293
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Registered Address:
C-101, Embassy 247, L.B.S. Marg,
Vikhroli (West), Mumbai - 400083.
Tel: +91 22 4918 6000
www.in.mpms.mufg.com
Date : 03-10-2026
The Compliance Officer/ Company Secretary
SYMBIOTEC PHARMALAB LIMITED
385/2, PIGDAMBER, RAU
MHOW, INDORE
MADHYA PRADESH
INDORE
PINCODE : 453331
Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and
Participants) Regulations, 2018.
Dear Sir/Madam,
In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for
dematerialisation during the quarter ended 30th September 2026, were confirmed (accepted/rejected) to the depositories by us and
that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are
listed.
We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security
certificates received were mutilated and cancelled after due verification by the depository participant and the name of the
depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request
you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
Ashok Shetty
Sr. Vice President-Corporate Registry
MUFG Intime India Private Limited
A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services